Kymera Therapeutics, Inc. ($KYMR)
Filing Information
| Accession Number | 0001193125-26-295088 |
|---|---|
| Form Type | 4 |
| Filing Date | Jul 2, 2026 |
| Document | View SEC Filing |
Transactions
7
Total Shares
240,000
Total Value
$9,389,927.48
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Jul 1, 2026 | Exercise/Conversion | 80,000 | $2.08 | $166,400.00 | 746,568 | Direct | โ | View Details | |
Director | Common Stock | โ | Jul 1, 2026 | Sale | 1,883 | $112.80 | $212,411.06 | 744,685 | Direct | โ | View Details | |
Director | Common Stock | โ | Jul 1, 2026 | Sale | 6,626 | $113.98 | $755,203.65 | 738,059 | Direct | โ | View Details | |
Director | Common Stock | โ | Jul 1, 2026 | Sale | 24,105 | $114.96 | $2,771,002.33 | 713,954 | Direct | โ | View Details | |
Director | Common Stock | โ | Jul 1, 2026 | Sale | 44,050 | $115.69 | $5,096,069.62 | 669,904 | Direct | โ | View Details | |
Director | Common Stock | โ | Jul 1, 2026 | Sale | 3,336 | $116.56 | $388,840.82 | 666,568 | Direct | โ | View Details | |
Director | Stock Option (Right to Buy) | Derivative | Jul 1, 2026 | Exercise/Conversion | 80,000 | $0.00 | $0.00 | 135,559 | Direct | โ | View Details |